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Abstract 
Background: The 12-lead surface electrocardiogram (ECG) is a useful tool to predict both 
atrial and ventricular arrhythmias via P-wave and QT measurements and its derivatives. 
Polycythemia vera (PV) is a chronic myeloproliferative disorder associated with cardiovas-
cular events. The aim of this study was to assess ECG findings of patients with PV.  
Method and materials: Sixty patients with PV (34 male, mean age 58±11 years) and 60 age and 
gender-matched healthy volunteers were enrolled into the study. From the 12-lead surface 
ECG, P-wave and both conventional QT measurements and transmyocardial repolarization 
parameters (Tpeak-Tend interval (Tp-Te) and derivatives) were evaluated digitally by two expe-
rienced cardiologists. In addition, a novel parameter, Pi was calculated digitally as the standard 
deviation of the P-wave duration across the 12 ECG leads.  
Results: QT duration and corrected QT interval were significantly longer in the PV group 
compared to healthy controls (p<0.01 and p<0.01, respectively). The Tp-Te was longer and the 
Tp-Te/QT ratio was significantly higher in the PV group compared to the controls. P-wave 
analyses showed that all P-wave parameters including Pmax, Pmin, P dispersion, and Pi were 
significantly prolonged in PV patients compared to the controls. The increase of both Tp-Te 
and P max in the PV group was independent of age, BMI, diabetes and hypertension, gender, 
systolic  blood  pressure,  hemoglobin,  hematocrit,  left  atrial  dimension,  left  ventricular 
end-diastolic diameter and early deceleration time in a univariate analysis of co-variance 
model (F=11.097, p=0.001 and F=31.537, p=0.0001, respectively). 
Conclusion: The present study demonstrated that PV may be associated with electrocardio-
graphic abnormalities of both atrium and ventricle. 
Key words: Polycythemia Vera, electrocardiographic abnormalities, atrium, ventricle 
Introduction 
Polycythemia vera (PV) is a chronic myelopro-
liferative  disorder  characterized  by  increased  for-
mation of red blood cells. Bleeding and thrombosis 
are  major  causes  of  morbidity  and  mortality  in  pa-
tients with PV, occurring in 40 to 60% of the patients 
(1-2).  Thrombotic  complications  include  acute  cere-
brovascular events, myocardial infarctions, peripheral 
vascular  occlusions,  pulmonary  infarctions,  and  ve-
nous thromboses. The most common cause of death is 
myocardial infarction and heart failure (3). The pre-
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cise mechanism causing this thrombotic tendency is 
not yet well understood. The hematocrit is the only 
laboratory  parameter  that  shows  clear  association 
with thrombotic complications (4). 
 P-wave  measurements  are  frequently  used  in 
clinical  practice  to  predict  atrial  arrhythmias,  espe-
cially atrial fibrillation (AF). It is well known that AF 
is associated with thromboembolic events (5). PV is a 
myeloproliferative disorder associated with both hy-
perviscosity  and  increase  of  total  plasma  volume 
which  may  cause  atrial  abnormalities.  In  addition, 
relation  between  hyperviscosity  and  AF  was  previ-
ously  demonstrated  (6).  Caimi  et  al.  (6)  have  sug-
gested  that hyperviscosity  is  frequent  in  patients 
with AF.  Although  mechanisms  of  in  situ  arterial 
thrombosis are known, the issue of thromboembolism 
remains controversial in patients with PV (7). Poten-
tially,  AF  may  contribute  to  arterial  thrombus  for-
mation and embolism in patients with PV. However, 
P-wave measurements which are useful tool to pre-
dict  AF  have  not  yet  been  investigated  in  patients 
with PV. 
 Conventional QT parameters and transmyocar-
dial  repolarization  parameters  including  Tpeak-Tend 
interval  and  derivatives  (Tpeak-Tend  dispersion  and 
Tpeak-Tend/QT) have been used to predict cardiac ar-
rhythmias in a number of clinical conditions with in-
creased arrhythmia risk (8-10). About half a century 
ago,  left  ventricular  (LV)  hypertrophy  was  demon-
strated  in  patients  with  PV  by  using  12-lead  ECG. 
However,  repolarization  abnormalities  were  not  in-
vestigated  (11).  Nevertheless,  LV  hypertrophy  was 
related to increased total plasma volume (11). Poten-
tially  deleterious  effects  of  hyperviscosity  and  LV 
hypertrophy  on  repolarization  parameters  have  not 
yet been examined in patients with PV. In the present 
study,  we  aimed  to  evaluate  electrocardiographic 
P-wave characteristics and ventricular repolarization 
parameters in patients with PV. 
Method and Materials 
Study Population 
This is a cross-sectional case control study which 
was conducted at the hematology department, Selcuk 
University, in Konya, Turkey. Sixty PV patients (34 
males,  mean  age  58±11  years)  and  60  age-matched 
healthy  subjects  were  enrolled  into  the  study.  The 
diagnosis of PV was made according to World Health 
Organization  criteria  (12).  Included  patients  gave 
their verbal and written consent for participation in 
the study. The study was approved by the local ethi-
cal committee of Selcuk University. All the patients in 
PV group used acetylsalicylic acid (100 mg per day) 
for the prophylaxis of thrombosis. Most of the patients 
(45 of 60 patients, 75%) were on hydroxyurea (HU) 
(1.0 mg daily) treatment. Exclusion criteria were: his-
tory of coronary artery disease, congestive heart fail-
ure,  congenital  or  acquired  arrhythmia  syndromes, 
use of drugs that lengthen the QT interval, current AF, 
bundle  branch  block,  atrioventricular  blocks,  and 
unmeasurable T waves (<0.15 mV) on surface ECG. 
Blood  pressure  was  measured  with  a  mercury 
sphygmomanometer  according  to  ESC/ESH  guide-
lines (13).  
EGG measurements 
All patients had a standard surface 12-lead ECG 
recorded with a 50 mm/s paper speed at 10 mm/1mV 
amplitude. ECGs were performed while the patients 
were supine and breathing normally. The ECGs were 
scanned  at  a  600  dpi  resolution  and  measurements 
made by electronic cursor from the screen by two ex-
perts who were blinded to the clinical status of the 
study population. Three consecutive ECG complexes 
were analyzed and given averaged measures for each 
lead.  
 
Regional and transmyocardial repolarization 
ECG parameters 
The QT intervals were measured from the onset 
of the first deflection of the QRS complex to the end of 
the T wave in all the 12 leads. If the T wave was flat or 
the end of the T wave was difficult to define, or if the 
T wave amplitude  was <0.15 mV, the lead was ex-
cluded  from  the  measurement.  The  end  of  the  QT 
interval  was  defined  as  the  intersection  of  terminal 
part of the T wave and the isoelectric line. If a U wave 
interrupted the T wave before it returned to baseline, 
the end of the QT interval was defined as the nadir 
between T and U waves. Corrected QT interval (cQT) 
was calculated using Bazett’s formula (cQT=QT/√R-R 
interval). cQT dispersion (cQTd) was defined as the 
difference  between  maximum  cQT  and  minimum 
cQT. The interval from the trigger point (QRS onset) 
to  the  peak  of  T-wave  was  defined  as  QT  peak 
interval.  
 Tp-Te  interval  was  defined  as  the  interval  be-
tween QT peak and QT end (Tp-Te=QTend-QTpeak). 
The  difference  between  maximum  Tp-Te  and  mini-
mum  Tp-Te  was  defined  as  Tp-Te  dispersion.  The 
(Tp-Te)/QT ratio was also calculated (Figure 1). Intra- 
and inter-observer difference of Tp-Te was 7.7% and 
9.8%, respectively.  Int. J. Med. Sci. 2012, 9 
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Figure 1. Measurement of repolarization parameters on 12-lead ECG sample. 
 
P-wave measurements 
P-wave  indices  (P  max,  P  min,  and  Pd)  were 
measured in all 12 leads. P max was defined as the 
longest  and  P  min  as  the  shortest  P-wave  duration 
measured from the 12-lead ECG. Pd was defined as 
the difference between P max and P min (Pd=P max-P 
min). Pi was calculated digitally as the standard de-
viation (SD) of the P-wave duration across the 12 ECG 
leads. The intraobserver and interobserver coefficients 
of  variation,  standard  deviation  of  differences  be-
tween two observations divided by the mean value 
and  expressed  as  a  percentage,  for  the  P-wave  dis-
persion were found to be 8.8% and 3.8%, respectively.  
Conventional Echocardiography 
Examinations  were  performed  with  a  Philips 
EnVisor  C  HD  ultrasound  machine  (Royal  Philips 
Electronics,  Bothell,  WA,  USA)  with  a  2.5  MHz 
transducer  by  two  experienced  cardiologists,  who 
were blinded to the patients’ clinical and laboratory 
status.  All  measurements  were  performed  during 
normal respiration. The LV ejection fraction (EF) was 
assessed  by  the  modified  biplane  Simpson  method 
(14) and the mean of three consecutive measurements 
was  used.  Cardiac  dimensions  were  measured  ac-
cording to the recommendations of the American So-
ciety  of  Echocardiography  (ASE)  by  M-mode  and 
two-dimensional (2D) echo (15). 2D mode echocardi-
ography was used to assess the LV mass (LVM) using 
the methodology of Devereux et al. (16).  
Statistical analysis 
The statistical analyses were performed with the 
help  of  the  Statistical  Package  for  Social  Sciences 
(SPSS for Windows) software (version 15.0) (SPSS Inc., 
Chicago, IL, USA). All data are expressed as the mean 
± SD. Differences between parametric variables of the 
two groups were assessed by the Student-t test. The 
relation between the categorical variables was deter-
mined by the chi-square test. The distribution of the 
variables  was  analyzed  with  the  Kolmogor-
ow-Smirnow  test.  A  Univariate  Analysis  of  Covari-
ance (ANCOVA) was applied to adjust for differences 
in  age,  body  mass  index  (BMI),  diabetes,  hyperten-
sion, gender, systolic blood pressure (SBP), hemoglo-
bin, hematocrit, left atrial dimension (LAD), left ven-
tricular  end-diastolic  diameter  (LVEDD)  and  early 
deceleration time (EDT) in general linear model. Tp-Te 
and/or P max were accepted as dependent variables, 
patient group was entered as a fixed factor and other 
variables,  age,  BMI,  diabetes,  hypertension,  gender, 
SBP, hemoglobin, hematocrit, LAD, LVEDD and EDT 
were entered as covariates into the ANCOVA model. 
A p-value under 0.05 was considered statistically sig-
nificant.  Power  analysis  was  performed  by  using  a 
Minitab 16 packet program. Sample volume was cal-
culated as 56 for each group to determine 10 ms dif-
ference of Tp-Te with 80% power. Because of proba-
bility of inadequate record quality of ECGs, a total of 
60 subjects were enrolled to study.  
Results 
The  demographic,  general,  and  echocardio-
graphic  characteristics  of  the  study  population  are 
listed in Table 1. There were no significant differences 
between  the  groups  regarding  to  age,  gender, 
body-mass index, or blood pressure levels. Hemoglo-
bin and hematocrit levels were significantly higher in 
the PV group than in the control group (p<0.01 and 
p<0.01, respectively). The presence of diabetes melli-Int. J. Med. Sci. 2012, 9 
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tus  and  hypertension  was  similar  between  groups 
(Table  1).  All  patients  were  under  antihypertensive 
and  oral  antidiabetic  treatments.  The  main  antihy-
pertensive medication of study population was angi-
otensine-converting  enzyme  inhibitors.  Of  the  2D 
echocardiographic  measurements,  LV  dimensions, 
and ejection fraction (EF) were similar in both groups; 
only LVM was significantly elevated in the PV group 
compared to the healthy controls (160±36 g vs. 135±34 
g, p=0.04; respectively) (Table 1).  
 
Table 1. Demographic, laboratory, and echocardiographic 
characteristics of the study population. 
  Control  PV  p-Value 
(n=60)  (n=60)   
Age (years)  55±10  58±10  NS 
Gender: Fe-
male / Male (n) 
31/29  26/34  NS 
HT (n)  21  19  NS 
DM (n)  10  7  NS 
BMI (kg/m2)  25±1.6  27±2.0  NS 
SBP (mmHg)  121±12  128±20  NS 
DBP (mmHg)  76±7  81±16  NS 
Heart rate 
(bpm) 
75±8  76±9  NS 
Hemoglobin 
(g/dL) 
13.3±1.2  15.7±1.9  <0.01 
Hematocrit (%)  42.2±2.5  48.7±6.6  <0.01 
LVEDD (cm)  4.5±0.3  4.6±0.5  NS 
LVESD (cm)  2.7±0.3  2.9±0.5  NS 
IVS (cm)  1.0±0.2  1.0±0.1  NS 
PW (cm)  0.9±0.1  0.9±0.1  NS 
EF Simpson 
(%) 
62±4  62±5  NS 
LVM (gr)  135±34  160±36  0.04 
LA (cm)  3.4±0.4  3.5±0.5  NS 
HT, hypertension; BMI. Body-mass index; SBP. Systolic blood 
pressure; DBP. Diastolic blood pressure; LVEDD, left ventricle 
end-diastolic dimension; LVESD, left ventricle end-systolic dimen-
sion; IVS, interventricular septum; PW, posterior wall; EF, ejection 
fraction; LVMI, left ventricular mass ; LA, left atrium; NS. 
Non-significant (p>0.05). 
 
 
 Twelve-lead surface ECG analysis of atrial and 
ventricular  arrhythmia  indices  are  demonstrated  in 
Table 2. QT and QTc were significantly prolonged in 
patients  with PV compared to controls (p<0.01 and 
p<0.01, respectively). Other conventional QT param-
eters  were  similar  between  the  two  groups.  Trans-
myocardial repolarization parameters including Tp-Te 
and  Tp-Te/QT  were  significantly  higher  in  the  PV 
group compared to the healthy subjects (Tp-Te p=0.003 
and  Tp-Te/QT  p=0.02,  respectively)  (Figure  2). 
(Tp-Te)d was pretend to be increased in PV patients 
compared  to  controls  (p=0.07)  (Table  2).  We  have 
found  that  in  PV  group,  some  P  wave  parameters 
were  positively  correlated  with  ventricular 
abnormality parameters compared to healthy controls 
(Table  3).  In  addition,  patients  with  P-wave 
abnormalities did not present with QT prolongation 
(Table 4).  
 
Table 2. Electrocardiographic parameters of the PV group 
and controls. 
   Controls  PV  p-Value 
(n=60)   (n=60)   
QT (ms)  372±32  394±29  <0.01 
QTd (ms)  44±17  47±18  NS 
QTp (ms)  287±31  297±25  0.07 
(QTp)d (ms)  31±13  36±13  0.08 
QTc (ms)  416±25  445±31  <0.01 
cQTd (ms)  50±21  53±21  NS 
Tp-Te (ms)  86±16  97±17  <0.01 
(Tp-Te)d (ms)  39±12  45±19  0.07 
Tp-Te/QT   0.23±0.04  0.24±0.04  0.02 
QRS duration 
(ms) 
93±12  103±13  <0.01 
Heart rate 
(bpm) 
76±11  78±13  NS 
P max (ms)  109±13  122±11  <0.01 
P min (ms)  78±12  87±12  <0.01 
P disp (ms)  30±9  35±8  0.01 
P index (ms)  9.8±2.9  11.3±2.9  <0.01 
QTd, QT dispersion; QTp, peak QT; (QTp)d, peak QT dispersion; 
QTc, corrected QT; cQTd; corrected QT dispersion; Tp-Te, difference 
between T-peak and T-end; (Tp-Te)d, Tp-Te dispersion. 
 
 
 Tp-Te was increased in the PV group independ-
ent of demographic and echocardiographic findings 
such  as  age,  BMI,  sex,  hemoglobin,  hematocrit, 
LVEDD,  EDT,  and  LAD  in  the  ANCOVA  model 
(F=11.097 and p=0.001). Tp-Te was also related with 
DM  and  pretends  to  be  related  with  HT  in  the 
ANCOVA model (Table 5).  
 Twelve-lead  surface  ECG  analysis  of  P-wave 
parameters is presented in Table 2. P max, P min, Pd, 
and Pi showed significantly higher values in the PV 
group compared to the controls (Figure 3 and 4). The 
difference of P max between the two groups was in-
dependent of age, BMI, diabetes, hypertension, gen-
der, SBP, hemoglobin, hematocrit, LAD, LVEDD and 
EDT in the ANCOVA model (F=31.537 and p=0.0001). 
Also,  hypertension  and  diabetes  were  independent Int. J. Med. Sci. 2012, 9 
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predictors  of  P  max  (F=9.808,  p=0.002 and  F=4.793, 
p=0.03, respectively). Pmax pretends to be increased 
with age in the ANCOVA model            (F= 3.809, 
p=0.06). Statistically, the effect of PV on the ECG was 
stronger  on  Pmax  than  on  Tp-Te  according  to  the 
ANCOVA analysis (Table 5).  
 
Table 3. Correlations between P-wave and ventricular repolarization parameters. 
  QT  QTc  Tp-Te  (Tp-Te)d  Tp-Te/QT 
PV  C  PV  C  PV  C  PV  C  PV  C 
Pd  r  0.01  0.07  0.32  0.02  0.13  0.06  0.06  0.05  0.14  0.08 
p  0.94  0.57  0.01  0.87  0.32  0.64  0.64  0.71  0.27  0.52 
Pi  r  0.10  0.02  0.36  0.06  0.20  0.05  0.16  0.03  0.18  0.06 
p  0.42  0.89  0.005  0.66  0.13  0.72  0.22  0.82  0.17  0.67 
P max  r  0.38  0.27  0.31  0.22  0.32  0.18  0.48  0.05  0.18  0.66 
p  0.003  0.04  0.02  0.09  0.01  0.16  0.000  0.72  0.17  0.62 
P min  r  0.36  0.24  0.04  0.23  0.20  0.25  0.41  0.01  0.06  0.15 
p  0.004  0.06  0.76  0.07  0.13  0.05  0.001  0.92  0.65  0.26 
PV, polycythemia vera; C, controls. 
 
Table 4. The frequency of patients with PV and controls according to abnormal P max and QTc values. 
  P max < 120 ms  P max ≥ 120 ms  p-Value 
PV  QTc < 470 ms  19  32   
0.32 
QTc > 470 ms  3  7 
C  QTc < 470 ms  41  19   
--- 
QTc > 470 ms  0  0 
PV, polycythemia vera; C, controls. 
 
Table 5. Results of Univariate Analysis of Variance (ANCOVA) for the Tp-Te and P max. 
Variables  Dependent variables  Mean square  F  p-Value  Model R2 
Patient group  Tp-Tea  2902.814  11.097  0.001  0.12 
P maxb  4652.813  31.537  0.0001  0.23 
BMI  Tp-Te  67.570  0.280  0.59  0.13 
P max  4.205  0.028  0.87  0.35 
Age 
 
Tp-Te  136.296  0.496  0.483  0.09 
P max  566.442  3.809  0.06  0.22 
Gender  Tp-Te  43.572  .158  0.692  0.10 
P max  6.423  0.042  0.838  0.18 
DM 
 
Tp-Te  1698.926  6.495  0.012  0.12 
P max  707.089  4.793  0.03  0.23 
HT  Tp-Te  814.922  3.028  0.08  0.11 
P max  1390.708  9.808  0.002  0.26 
Systolic BP  Tp-Te  5.575  0.022  0.88  0.05 
P max  263.796  2.009  0.16  0.18 
Hb  Tp-Te  27.846  0.110  0.74  0.07 
P max  155.396  1.191  0.28  0.18 
Htc  Tp-Te  4.150  0.016  0.89  0.07 
P max  321.301  2.519  0.12  0.20 
LA  Tp-Te  3.863  0.015  0.90  0.07 
P max  154.268  1.182  0.28  0.18 
LV EDD  Tp-Te  215.007  0.860  0.36  0.08 Int. J. Med. Sci. 2012, 9 
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P max  119.653  0.912  0.34  0.18 
EDT  Tp-Te  281.420  1.131  0.29  0.08 
P max  18.015  0.135  0.71  0.17 
LV mass  
 
Tp-Te  131,697  0.524  0.47  0.08 
P max  28,527  0.215  0.64  0.17 
QRS duration 
 
Tp-Te  2521,874  9,907  0,002  0,15 
P max  1667,183  11,804  0,001  0,27 
In the ANCOVA analysis, Tp-Te and/or P max were accepted as dependent variables, patient groups were entered as a fixed factor and 
other variables were defined as covariates.  
 a R2=0.18, adjusted R2=0.12 for the Tp-Te.  
b R2=0.45, adjusted R2=0.41 for the P max in theANCOVA model. 
 
 
 
Figure 2. Mean values of transmyocardial repolarization parameters. 
 
 
Figure 3. The graph depicts the mean duration of P wave maximum (P max) and P wave minimum (P min). Int. J. Med. Sci. 2012, 9 
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Figure 4. Mean values of P wave dispersion (P disp) and P index. 
 
Discussion 
The  present  study  demonstrated  that  P-wave 
measurements showed significantly higher values in 
patients  with  PV  compared  to  healthy  subjects.  In 
addition, most of repolarization parameters (QT, QTc, 
Tp-Te, and Tp-Te/QT) were significantly prolonged in 
patients with PV. The relationship between PV and 
ECG  parameters  were  independent  of  demographic 
features.  The  present  study  is  the  first  one,  where 
comprehensive analysis of both ventricular repolari-
zation parameters and P-wave characteristics in PV 
patients was performed. 
Recently, non-invasive ECG methods have been 
introduced to assess the atrial arrhythmia risk of pa-
tients. P-wave duration and dispersion are considered 
to  be  one  of  the  most  important  non-invasive  ECG 
markers (17-18). The increase in P-wave duration is 
considered an indicator of atrial conduction prolon-
gation and, thus, might be useful in atrial arrhythmia 
risk stratification. Pd constitutes a recent contribution 
to the field of noninvasive ECG-prediction of AF (19). 
Pd represents non-homogeneous and anisotropic dis-
tribution of connections between myocardial fibers in 
atrial tissue (20). Non-homogeneity of atrial conduc-
tion, i.e. Pd prolongation, was considered as an inde-
pendent predictor of AF. In the present study, all of 
the P wave measurements (Pd, P max, P min, and Pi) 
were increased in the PV group compared to the con-
trol group. PV is frequently associated with throm-
botic  complications.  Also  patients  with  AF  have  an 
increased  risk  for  thromboembolic  events  (5).  The 
relationship  between  PV  and  AF  with  regard  to 
thrombotic complications is an unknown issue. Atrial 
electrical  abnormalities  have  not  been  investigated 
before  in  patients  with  PV.  Based  on  the  P-wave 
measurements, our study indicates that patients with 
PV may have an increased risk of AF development. In 
addition, Pi was added to the P-wave measurements 
as a novel parameter in the present study. Pi was in-
creased  in  the  PV  group  compared  to  the  control 
group. It is thought that Pi accounts for the differences 
in atrial conduction across different vectors (21).  
 Increased  non-homogeneity  in  the  repolariza-
tion phase of the myocardial action potential can pre-
cipitate malignant ventricular arrhythmias (ventricu-
lar tachycardia and fibrillation) (22). The duration of 
the action potential varies between different parts of 
the  myocardium  and  this  difference  is  defined  as 
dispersion  of  repolarization  so  called  regional  re-
polarization.  A  regional  repolarization  abnormality 
was represented with conventional QT measurements 
(QTc, QTd, and etc) in ECG. Regarding transmyocar-
dial repolarization, there are three layers in the myo-
cardium: the endocardial, the M-cell, and the epicar-
dial layer. The myocardial layers can be at different 
repolarization  phases  creating  transmyocardial 
non-homogeneities.  This  transmyocardial 
non-homogeneity  are  determined  by  the  ECG  pa-
rameters Tp-Te, (Tp-Te)d, and Tp-Te/QT ratio in ECG. 
Thus, an inhomogeneity of both regional and trans-
myocardial  repolarization  becomes  substrates  for 
re-entry causing ventricular arrhythmias in different 
populations (23). In the present study, although QT 
and QTc were higher in the PV group compared to 
controls, dispersion parameters did not show signifi-Int. J. Med. Sci. 2012, 9 
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cant  difference  between  the  two  groups.  Also  we 
found higher Tp-Te duration and Tp-Te/QT ratio in PV 
patients  compared  to  the  healthy  subjects.  The  in-
crease of Tp-Te in the PV group was independent of 
age, BMI, diabetes and hypertension in a univariate 
analysis. Based on the study results, transmyocardial 
repolization  was  impaired  consistent  with  regional 
repolarization measurements in PV group. Although 
(Tp-Te)d was tended to be prolonged in PV patients, 
both  QTd  and  (Tp-Te)d  were  comparable  in  both 
group. The effect of PV on dispersion parameters was 
not as strong as measurements related to repolariza-
tion duration. 
 PV is mainly characterized with hyperviscosity. 
Hyperviscosity  is  associated  with  increase  of  total 
plasma  volume  and  reduced  O2  saturation  of  the 
erythrocytes  in  patients  with  PV  (24).  Thus,  hyper-
viscosity  may  result  in  an  increased  myocardial 
workload  and  tissue  ischemia  (25).  Myocardial  is-
chemia is associated with prolongation of repolariza-
tion parameters in patients with coronary heart dis-
ease (9, 26-27). Therefore, we speculated that hyper-
viscosity  may  cause  to  abnormal  repolarization  via 
tissue  ischemia.  In  addition,  although  patients  with 
clinically overt coronary artery disease were excluded 
from the study, subclinical atherosclerosis and silent 
myocardial  ischemia  may  affect  repolarization  pa-
rameters  in  the  study  group.  It  was  also  suggested 
that  there  is  a  strong  relation  between  arterial  is-
chemic  complications,  including  myocardial  infarc-
tion, and hematocrit levels in patients with PV (25). 
Recent studies have demonstrated that hyperviscosity 
is frequent in patients with non-valvular AF (6). Fur-
thermore, hyperviscosity is a possible risk factor for 
cerebrovascular  ischemic  complications  in  patients 
with AF (28). A possible explanation for the higher 
values of the P-wave parameters in PV patients might 
be related to accompanying hyperviscosity. In a uni-
variate analysis, although PV independently affected 
both  atrial  and  ventricular  parameters  independent 
from the patients’ demographic features, the effect of 
PV on the ECG was stronger on Pmax than on Tp-Te 
according to the ANCOVA model.  
 Nevertheless, LV hypertrophy secondary to in-
creased workload may also explain the ECG changes 
in PV patients. Prati et al. (11) firstly described ECG 
changes  secondary  to  LV  hypertrophy  in  patients 
with PV. Cobb and colleagues (24) discussed plasma 
rheology and physiologic consequences of PV, and LV 
hypertrophy was mentioned in this context. Current-
ly,  Devereux  et  al.  (29)  stated  that  increased  blood 
viscosity  (especially  patients  with  hematocrit  levels 
above 18 mg/dL) may be a potential determinant of 
cardiac hypertrophy in patients with systemic hyper-
tension. Therefore, we performed echocardiographic 
examination in PV patients in the present study. We 
found an increased LVM in the PV group. Although 
the  study  population  and  the  control  group  were 
similar  in  demographic  characteristics  (age,  gender, 
blood pressure, BMI, physical condition), an increase 
in LVM was attributed to PV. In addition, previous 
studies have demonstrated that QT, QTd and Tp-Te 
prolongation  well  correlates  with  LVM  (30-32).  In 
conclusion, hyper viscocity may affect repolarization 
parameters in several ways.  
 The relation between atrial and ventricular elec-
trical abnormality was also examined in the present 
study. The duration of QTc was positively corrected 
with Pd, Pi and Pmax in the PV group. In addition, 
QT and (Tp-Te)d were positively correlated with Pmax 
and Pmin in the PV group. In the control group, there 
was no linear relation between atrial and ventricular 
electrocardiographic  measurements.  Thus,  PV  may 
concordantly impair both ventricular and atrial elec-
trical activities. However, power of linear association 
was  seen  as  a  mild  to  moderate.  When  we  used  a 
universal cut-off value for group comparisons, there 
was no difference between groups. It may be related 
with small sample size and mild to moderate associa-
tion. Logically, PV affected both atrial and ventricular 
electrical activations with same pathway. It needs to 
future investigations in this area. 
 The  main  limitation  is  that  this  study  is  a 
cross-sectional study and large prospective random-
ized studies are needed to clarify whether these ab-
normal  ECG  parameters  translate  into  clinical  out-
comes  and  enable  us  to  predict  future  arrhythmia 
development.  Most  of  the  PV  patients  were  under 
cytoreductive  therapy,  and  our  results  may  not  be 
applicable  to  patients  not  undergoing  this  kind  of 
therapy.  More  importantly,  P-wave  measurements 
and  ventricular  abnormality  parameters  of  PV  pa-
tients with sinus rhythm were performed using the 
12-lead  ECG;  however,  rhythm  Holter  monitoring 
and/or  an  event  recorder  were  not  performed  on 
study  participants  to  eliminate  paroxysmal  AF  and 
ventricular arrhythmias.  
 In conclusion, our study demonstrated that PV 
may affect both P-wave and ventricular repolarization 
parameters.  
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